期刊文献+

磁共振扩散加权成像表观扩散系数对局部进展期乳腺癌新辅助化疗的评估——不同测量方法比较 被引量:9

Assessment of apparent diffusion coeffient in breast cancer response to neoadjuvant chemotherapy:Comparison of different measuring method
下载PDF
导出
摘要 目的分析新辅助化疗(NAC)前后乳腺癌灶最小表观扩散系数(ADC)值对NAC病理反应性的评估效能。方法36例患者,根据术后病理反应性结果(Miller&Payne分级)分为MHR与NMHR两组,采用最小ADC值法于b=1000s/mm2图像上测量癌灶的ADC值。对每个病理组癌灶及正常腺体的ADC值、两组NAC前、NAC第2周期后、NAC第4周期后MR测量的癌灶最小ADC值及其变化率(△ADC%)进行统计学分析。利用ROC曲线评估癌灶最小ADC值对NAC病理反应性。结果NAC第2周期后,MHR组癌灶最小ADC值[(1.19±0.18)×10-3mm2/s]及△ADC1%[中位21.18%,(范围4.27%~50.00%)]分别与NMHR组最小ADC值[(0.98±0.16)×10-3mm2/s]及△ADC1%[中位8.53%,(范围-24.52%~64.79%)]两组间差异有统计学意义(P<0.05);NAC第4周期后,最小ADC值[(1.45±0.22)×10-3mm2/s]及△ADC2%[中位1.04%,范围1.71%~117.24%]均显著高于NMHR组[(1.06±0.19)×10-3mm2/s、中位16.84%,(范围7.68%~61.97%)],差异有统计学意义(P<0.05)。NAC第2周期后癌灶最小ADC值及△ADC1%ROC曲线下面积分别为0.77、0.82。NAC第4周期后癌灶最小ADC值及△ADC2%ROC曲线下面积分别为0.85、0.89。结论最小ADC值法比平均ADC值法能更早期评估进展期乳腺癌NAC的疗效。 Objective To investigate the clinical value of tumor's minimum apparent diffusion coefficient(ADC)in assessing pathologic response in locally advanced breast cancer treated with neoadjuvant chemotherapy(NAC).Methods Thirty-six patients with pathologically confirmed locally advanced breast cancer were divided into major histological response(MHR)group and non-major histological response(NMHR)according to the pathologic response(Miller Payne grading system).The minimum ADC value(b=1000 s/mm 2)and its changing rate(ADC%)of tumors were analyzed before chemotherapy,after the second cycle and the fourth cycle in NAC.ROC was assessed to obtain the of minimum ADC value for pathologic response.Results After the 2nd cycle,the minimum ADC value([1.19±0.18]×10^-3 mm 2/s)and ADC1%(median 21.18%,[4.27%-50.00%])in MHR were significantly higher than those([0.98±0.16]×10^-3 mm 2/s;median 8.53% [-24.52%-64.79%])in NMHR(P〈0.05).After the 4th cycle,the minimum ADC value([1.45±0.22]×10^-3 mm 2/s)and ADC2%(median 1.04%,range 1.71%-117.24%)in MHR were significantly higher than those in NMHR([1.06±0.19]×10^-3 mm 2/s;median 16.84%,range 7.68%-61.97%),respectively(P〈0.05).After the 2nd cycle,the AUC of the minimum ADC value and ADC1% were 0.77 and 0.82,respectively(P〈0.05).After the 4th cycle,the AUC of the minimum ADC value and ADC2% were 0.85,and 0.89,respectively(P〈0.05).Conclusion The method of minimum ADC value can assess the advanced breast cancer response of NAC earlier.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第11期2036-2039,共4页 Chinese Journal of Medical Imaging Technology
基金 医学物理和工程北京市重点实验室开放课题:乳腺癌MR诊断(2008P03)
关键词 乳腺肿瘤 磁共振成像 新辅助化疗 表观扩散系数 Breast neoplasms Magnetic resonance imaging Neoadjuvant chemotherapy Apparent diffusion coeficient
  • 相关文献

参考文献14

  • 1刘溢,谢敬霞,韩鸿宾,杨渝平,刘淳.磁共振扩散加权成像在乳腺肿瘤的初步应用[J].中国医学影像技术,2003,19(5):548-551. 被引量:38
  • 2金光韦,蔡幼铨,安宁豫,李席如,刘梅,王建东.表观扩散系数预测腺癌新辅助化疗反应初探[J].中华放射学杂志,2008,42(3):289-293. 被引量:19
  • 3Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes preced size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging, 2006,24(7) :843-847.
  • 4Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast, 2003,12(5) : 320-327.
  • 5Vande Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results form the European, Organization for Research and Treatment of Cancer trial 10902. Clin Oncol, 2001,19(22) :4224-4237.
  • 6Archer CD, Parton M, Smith IE, et al. Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer. Br J Cancer, 2003,89(6) :1035-1041.
  • 7Sharma U, Danishad KK, Seenu V, et al. Longitudinal study of the assessment by MRI and diffusionoweighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed, 2009,22(1) : 104-113.
  • 8Roth Y, Tichler T, Kostenich G, et al. Higb-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology, 2004,232(3) :685-692.
  • 9Yamashita Y, Kumabe T, Higano S, et al. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas. Neurol Res, 2009,31 (9) : 940-946.
  • 10Kikuchi T, Kumabe T, Higano S, et al. Minimum apparent diffusion coefficient for the differential diagnosis of ganglioglioma. Neurol Res, 2009, Jan 9, [Epub ahead of print].

二级参考文献19

  • 1陈蓉,龚水根,张伟国,陈金华,何双梧,刘宝华,李增鹏.乳腺肿瘤动态增强MRI对比剂空间分布及其与微血管密度的相关性研究[J].临床放射学杂志,2004,23(10):857-861. 被引量:17
  • 2赵斌,蔡世峰,高佩虹,彭洪娟.MR扩散加权成像鉴别乳腺良恶性病变的研究[J].中华放射学杂志,2005,39(5):497-500. 被引量:146
  • 3Charfare H, Limongelli S, Purushotham AD. Neoadjuvant chemotherapy in breast cancer ( Review ). Br J Surg, 2005,92 : 14-23.
  • 4Yeh E, Slanetz P, Kopans DB, et al. Prospective comparision of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. A JR, 2005, 184: 868-877.
  • 5Fisher ER, Wang J, Bryant J, et al. Pathobiology of preoperative chemotherapy : findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer,2002,95:681-695.
  • 6Rouzier R, Mathieu MC, Sideris L, et aL Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Cancer,2004,101:918-925.
  • 7Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast- enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology, 1994, 191: 633-638.
  • 8Szafer A, Zhong J, Gore JC. Theoretical model for water diffusion in tissues. Ma- Reson Meal,1995,33:697-712.
  • 9Chinnaiyan AM, Prasad U, Shankar S, et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA,2000,97:1754-1759.
  • 10Stegman LD, Rehemtulla A, Hamstra DA, et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther, 2000, 7: 1005-1010.

共引文献52

同被引文献147

  • 1贾丽,于金明,王仁本,巩合义,李金丽,焦玉红.^(18)F-FDG PET/CT对乳腺癌新辅助化疗疗效预测的价值[J].中国肿瘤临床与康复,2006,13(3):215-218. 被引量:10
  • 2凡庆东,姜军,杨新华,范林军,周艳.乳腺癌p53、cerbB-2表达与TE方案新辅助化疗疗效的关系[J].重庆医科大学学报,2007,32(10):1059-1061. 被引量:8
  • 3Chagpar AB,Middleton LP,Sahin AA,et al.Accuracy of physical examination,ultrasonography,and mammography in predicting residual pathologic tumor size in patients treated with neondjuvant chemotherapy[J].Ann Surg,2006(2),243:257-264.
  • 4Sperber F,Weinstein Y,Sarid D,et al.Preoperative clinical,mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer[J].Isr Med Assoc J,2006,8:342-346.
  • 5Roubidoux MA,LeCarpentier GL,Fowlkes JB,et al.Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy[J].J Ultrasound Med,2005,24:885-895.
  • 6Kuo WH,Chen CN,Hsieh FJ,et al.Vascularity change and tumor response to neoadjuvant chemotherapy for advanced breast cancer[J].Ultrasound Med Biol,2008,34(6):857-866.
  • 7Doot RK,Dunnwald LK,Schubert EK,et al.Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer respoase to therapy,including the effect of granulocyte CSF[J].J Nucl Med,2007,48(6):920-925.
  • 8Duch J,Fuster D,Munoz M,et al.18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer[J].Eur J Nucl Med Mol Imaging,2009,36(10):1551-1557.
  • 9Akazawa K,Tamaki Y,Taguchi T,et al.Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy[J].Breast J,2006,12(2):130-137.
  • 10Berry DA,Cirrincione C,Henderson IC,et al.Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer[J].JAMA,2006,295(14):1658-1667.

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部